Andrew M Miller Selected Research

Andrew M Miller Research Topics

4	Inflammation (Inflammations) 09/2011 - 04/2010
3	Parkinson Disease (Parkinson's Disease) 01/2019 - 05/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2011 - 04/2011
2	Liver Diseases (Liver Disease) 07/2010 - 05/2010
2	Fibrosis (Cirrhosis) 12/2009 - 02/2007
2	Portal Hypertension 12/2009 - 02/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Dystonic Disorders (Writer's Cramp) 05/2016
1	Dystonia (Limb Dystonia) 05/2016
1	Non-alcoholic Fatty Liver Disease 09/2011
1	Neoplasms (Cancer) 08/2011
1	Carcinogenesis 08/2011
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 05/2011
1	Necrosis 05/2010
1	Insulin Resistance 11/2008
1	Endotoxemia 02/2007

4	CytokinesIBA 09/2011 - 05/2010
3	Interleukin-6 (Interleukin 6)IBA 09/2011 - 04/2010
3	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2011 - 05/2010
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2011 - 05/2010
2	Ethanol (Ethyl Alcohol)IBA 09/2011 - 04/2010
2	Thromboxane A2 (A2, Thromboxane)IBA 12/2009 - 02/2007
1	Levodopa (L Dopa)FDA LinkGeneric 05/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2011
1	InterleukinsIBA 09/2011
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 08/2011
1	InterferonsIBA 04/2011
1	Poly I-CIBA 04/2011
1	Interleukin-17 (Interleukin 17)IBA 07/2010
1	ChemokinesIBA 07/2010
1	Interleukin-22 (IL-22)IBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010
1	TOR Serine-Threonine KinasesIBA 11/2008
1	Sirolimus (Rapamycin)FDA Link 11/2008
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2008
1	Endothelin-1 (Endothelin 1)IBA 02/2007